We're sorry, but your current browser configuration is not compatible with this site. Please enable JavaScript or switch to a JavaScript-capable browser. Learn how to enable JavaScript

Content continues after advertisement

Nutritional Assessment in a Dog with Chronic Enteropathy

Linda Toresson, DVM, Evidensia Specialist Animal Hospital, Helsingborg, Sweden

Gregg K. Takashima, DVM, WSAVA Global Nutrition Committee Series Editor

Kara M. Burns, MS, MEd, LVT, VTS (Nutrition), Olathe, Kansas

Nutrition

|April 2018|Peer Reviewed

This is a filled error message

Account sign in.

To access full articles on www.cliniciansbrief.com, please sign in below.

Forgot password?

Create Account

Trusted content.

Tailored to you.

For free.

Create an account for free

Want free access to the #1 publication for diagnostic and treatment information? Create a free account to read full articles and access web-exclusive content on www.cliniciansbrief.com.

THE CASE

A 4.5-year-old intact female shar-pei was presented for chronic recurrent diarrhea, which was either watery or mucoid, of more than a year’s duration. Vomiting and hyporexia developed the month before presentation and was associated with mild weight loss. The dog was the only pet in the household and was up-to-date on vaccinations and flea/tick preventives; heartworm prevention was unnecessary, as there is no heartworm disease in Sweden or northern Europe, where this dog lives.

Physical Examination

The patient had to be sedated for physical examination due to temperament. BCS was 4/9, with a muscle condition score showing mild muscle atrophy and a dull hair coat. Despite chronic diarrhea, no signs of dehydration were observed. All other vital parameters were within normal limits. Rectal palpation was painful despite sedation.

Dietary History

Several therapeutic diets labeled intestinal, including a high-fiber diet, had been tried throughout the last year without clinical improvement. The protein sources of those diets included chicken, egg, and turkey, and the owners sometimes gave treats such as cold cuts and table scraps. Water intake remained the same throughout the year. Metronidazole had been prescribed on several occasions; diarrhea would cease with metronidazole but would recur each time after discontinuation of therapy.

Diagnostic Results

Diagnostics included screening for intestinal parasites, CBC, serum chemistry profile, urinalysis, and a GI panel, including trypsin-like immunoreactivity, cobalamin, and folate. No intestinal parasites were detected. Subnormal serum concentrations of folate, cobalamin, and cholesterol were detected (Table). CBC and serum chemistry profile were otherwise unremarkable.

Endoscopy of the stomach and small and large intestine were performed. Histopathology of biopsies of the small and large intestine revealed a moderate lymphocytic-plasmacytic enteritis, with a moderate degree of villous atrophy, and moderate lymphocytic-plasmacytic colitis.

TABLE

SUBNORMAL SERUM CHEMISTRY RESULTS

Test	Reference Interval	Baseline	9 Weeks After Baseline	5 Months After Baseline
Cobalamin	251-908 ng/L (185 - 670 pmol/L)	231 ng/L (170 pmol/L)	705 ng/L (520 pmol/L)	250 ng/L (184 pmol/L)
Folate	7.7-24.4 µg/L (17.4 - 55.3 nmol/L)	3.5 µg/L (7.9 nmol/L)	35 µg/L (79.3 nmol/L)	25 µg/L (56.6 nmol/L)
Cholesterol	158-282 mg/dL (4.09 - 7.30 mmol/L)	124 mg/dL (3.21 mmol/L)	189 mg/dL (4.90 mmol/L)	N/A

DIAGNOSIS:

CHRONIC ENTEROPATHY

Treatment & Follow-Up

The dog’s diet was changed to a commercial lamb and rice novel single-source protein diet, and folate supplementation (5 mg PO q24h) was initiated. Treatment with prednisolone was initiated (initial dose, 1.5 mg/kg q24h) and slowly tapered over 6 months (maintenance dose, 0.2 mg/kg q48h). Several attempts to further taper the dose were made but would cause diarrhea to relapse. Four weekly cobalamin injections (800 µg) were administered according to Texas A&M University Gastrointestinal Laboratory recommendations (see Suggested Reading).

At follow-up 4 weeks after the last cobalamin injection, the dog’s stool had normalized, vomiting had stopped, and appetite returned. Serum cobalamin concentration, cholesterol, and folate had normalized (Table). Folate and cobalamin supplementation was stopped and prednisolone was further tapered to 0.5 mg/kg q48h.

At follow-up 3 months later, the dog had experienced 2 recurrences of diarrhea, and serum cobalamin concentrations had decreased to subnormal levels. A new parenteral cobalamin maintenance supplementation protocol was recommended; however, the owners were not interested in a new series of injections but were instead interested in oral cobalamin supplementation.

Oral cobalamin supplementation has been proven to be effective in humans with cobalamin deficiency,^1-5 and recent studies have confirmed its efficacy in dogs and cats with chronic enteropathy and hypocobalaminemia.^6-9 It offers an alternative to parenteral supplementation and may suit some owners better, as oral administration may be an easier and more cost-effective alternative to monthly injections, particularly for patients requiring long-term maintenance supplementation. Because oral supplementation in dogs with hypocobalaminemia had not been studied at the time of this case, the potential for failure of this therapy was carefully discussed with the owners before supplementation (1 mg PO q24h) was initiated.

At follow-up 2 months later, serum cobalamin concentration was higher than after the first series of injections and the dog was clinically stable. The dog has been on successful oral cobalamin maintenance therapy for 8 years.

ASK YOURSELF…

Diet in Disease is a series developed by the WSAVA, the Academy of Veterinary Nutrition Technicians, and Clinician’s Brief.

References

Berlin H, Berlin R, Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand. 1968;184(4):247-258.
Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92(4):1191-1198.
Castelli MC, Friedman K, Sherry J, et al. Comparing the efficacy and tolerability of a new daily oral vitamin B12 formulation and intermittent intramuscular vitamin B12 in normalizing low cobalamin levels: a randomized, open-label, parallel-group study. Clin Ther. 2011;33(3):358-371.
Bolaman Z, Kadikoylu G, Yukselen V, Yavasoglu I, Barutca S, Senturk T. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003;25(12):3124-3134.
Kim HI, Hyung WJ, Song KJ, Choi SH, Kim CB, Noh SH. Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol. 2011;18(13):3711-3717.
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Oral cobalamin supplementation in dogs with chronic enteropathies and hypocobalaminemia. J Vet Intern Med. 2016;30(1):101-107.
Toresson L, Steiner JM, Olmedal G, Larsen M, Suchodolski JS, Spillmann T. Oral cobalamin supplementation in cats with hypocobalaminaemia: a retrospective study. J Feline Med Surg. 2017;19(12):1302-1306.
Toresson L, Steiner JM, Razdan P, et al. Comparison of efficacy of oral and parenteral cobalamin supplementation in normalizing low cobalamin concentrations in dogs: a randomized controlled study. Vet J. 2018;232:27-32.
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Methylmalonic acid concentrations in dogs with hypocobalaminemia treated with oral versus parenteral cobalamin supplementation. J Vet Intern Med. 2017;31:39.
Luckschander N, Allenspach K, Hall J, et al. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. J Vet Intern Med. 2006;20(2):221-227.
Ruaux CG. Cobalamin in companion animals: diagnostic marker, deficiency states and therapeutic implications. Vet J. 2013;196(2):145-152.
Allenspach K, Wieland B, Grone A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med. 2007;21(4):700-708.
Batchelor DJ, Noble PJ, Taylor RH, Cripps PJ, German AJ. Prognostic factors in canine exocrine pancreatic insufficiency: prolonged survival is likely if clinical remission is achieved. J Vet Intern Med. 2007;21(1):54-60.
Volkmann M, Steiner JM, Fosgate GT, Zentek J, Hartmann S, Kohn B. Chronic diarrhea in dogs—a retrospective study in 136 cases. J Vet Intern Med. 2017;31(4):1043-1055.
Ruaux CG, Steiner JM, Williams DA. Early biochemical and clinical responses to cobalamin supplementation in cats with signs of gastrointestinal disease and severe hypocobalaminemia. J Vet Intern Med. 2005;19(2)155-160.
Kempf J, Hersberger M, Melliger RH, Reusch CE, Kook PH. Effects of 6 weeks of parenteral cobalamin supplementation on clinical and biochemical variables in cats with gastrointestinal disease. J Vet Intern Med. 2017;31(6):1664-1672.
Grützner N, Bishop MA, Suchodolski JS, Steiner JM. Association study of cobalamin deficiency in the Chinese Shar Pei. J Hered. 2010;101(2):211-217.
Fyfe JC, Jezyk PF, Giger U, Patterson DF. Inherited selective malabsorption of vitamin B12 in giant schnauzers. J Am Anim Hosp Assoc. 1989;29:533-539.
He Q, Madsen M, Kilkenney A, et al. Amnionless function is required for cubilin brush-border expression and intrinsic factor-cobalamin (vitamin B12) absorption in vivo. Blood. 2005;106(4):1447-1453.
Lutz S, Sewell AC, Reusch CE, Kook PH. Clinical and laboratory findings in border collies with presumed hereditary juvenile cobalamin deficiency. J Am Anim Hosp Assoc. 2013;49(3):197-203.
Fyfe JC, Hemker SL, Venta PJ, Stebbing B, Giger U. Selective intestinal cobalamin malabsorption with proteinuria (Imerslund-Grasbeck syndrome) in juvenile beagles. J Vet Intern Med. 2014;28(2):356-362.
Dandrieux, JR, Noble, PJ, Halladay LJ, McLean L, German AJ. Canine breed predisposition for marked hypocobalaminemia or decreased folate concentration assessed by a laboratory survey. J Small Anim Pract. 2013;54(3):143-148.
Steiner JM. Frequently asked questions: does lipemia interfere with the assays? Texas A&M University Gastrointestinal Laboratory website. http://vetmed.tamu.edu/gilab/service/faq#Lipemia. Accessed March 2, 2018.